Codeine may be considered a “weaker” opioid, but the nervous system does not grade opioids on a friendly little curve. When codeine is taken regularly, the body can adapt to its presence. Reducing the dose too quickly or stopping suddenly may then produce codeine withdrawal symptoms such as anxiety, sweating, muscle aches, nausea, diarrhea, and powerful cravings.
Withdrawal is often described as an extremely unpleasant case of the flu combined with insomnia and restlessness. Although it is not usually life-threatening by itself, complications can become serious. Vomiting and diarrhea may cause dehydration, uncontrolled symptoms may increase the chance of returning to opioid use, and reduced tolerance can make a later overdose more likely.
What Is Codeine Withdrawal?
Codeine is a short-acting opioid used in certain prescription pain medicines and, less commonly in the United States today, some cough products. The liver converts part of each dose into morphine, which contributes to codeine’s pain-relieving and sedating effects. Genetic differences in this conversion help explain why codeine can affect two people quite differently.
With repeated exposure, opioid receptors and other parts of the nervous system adjust to the drug. This adaptation is called physical dependence. When codeine suddenly disappears, systems that were being restrained by the opioid temporarily become overactive. The result is withdrawal: watery eyes, sweating, rapid heartbeat, intestinal distress, anxiety, and the peculiar feeling that every switch in the body has been turned on simultaneously.
Physical dependence is not automatically the same as addiction or opioid use disorder. A person can become dependent while taking codeine exactly as prescribed. Opioid use disorder involves a problematic pattern of use, such as impaired control, persistent use despite harm, or intense drug-seeking behavior. Either situation deserves respectful medical care rather than judgment.
Common Codeine Withdrawal Symptoms
The exact symptom pattern depends on the dose, duration and frequency of use, other medications, overall health, and whether codeine is stopped abruptly or tapered. Symptoms generally appear in stages rather than arriving in one dramatic wave.
Early symptoms
Early withdrawal reflects increasing nervous-system activity. Possible symptoms include:
- Anxiety, irritability, or an unsettled feeling
- Restlessness and difficulty sitting still
- Frequent yawning
- Watery eyes and a runny nose
- Sweating and clammy skin
- Muscle aches, joint pain, or back pain
- Headache
- Trouble falling or staying asleep
- Dilated pupils and increased sensitivity to light
- Cravings for codeine or another opioid
Symptoms near the peak
Digestive and autonomic symptoms often become more noticeable as withdrawal intensifies. These may include:
- Abdominal cramping
- Nausea or vomiting
- Diarrhea
- Goosebumps
- Chills alternating with hot flashes
- Trembling or muscle spasms
- Rapid breathing, increased heart rate, or elevated blood pressure
- Loss of appetite
- Difficulty concentrating
Many of these symptoms are summarized in the MedlinePlus overview of opioid withdrawal and the Cleveland Clinic clinical guide.
Lingering symptoms
After the intense physical phase passes, some people continue to experience fatigue, disrupted sleep, low mood, anxiety, reduced enjoyment, and intermittent cravings. These symptoms do not mean that recovery has failed. Sleep and stress-response systems may simply need more time to stabilize, particularly after prolonged or high-dose opioid exposure.
Codeine Withdrawal Timeline
Because codeine is relatively short-acting, symptoms can begin sooner than they do with long-acting opioids such as methadone. The following timeline is an estimate, not a countdown clock. Individual experiences vary considerably.
| Time after the last dose | What may happen |
|---|---|
| Approximately 8–24 hours | Anxiety, yawning, watery eyes, runny nose, sweating, restlessness, muscle aches, insomnia, and cravings may begin. |
| About 24–72 hours | Symptoms may intensify. Nausea, vomiting, diarrhea, abdominal cramps, chills, goosebumps, and rapid heartbeat can appear. |
| Days 4–7 | Acute physical symptoms commonly begin to ease, although sleep problems, low energy, stomach sensitivity, and cravings may remain. |
| Following weeks | Mood changes, fatigue, insomnia, and episodic cravings may persist, especially after long-term use or in people with opioid use disorder. |
A higher daily dose, longer period of regular use, abrupt discontinuation, co-occurring illness, and use of other substances may make withdrawal more severe or prolonged. The timeline can also change if the product contains another active ingredient. For example, many codeine tablets contain acetaminophen, but acetaminophen does not prevent opioid withdrawal and taking extra tablets can cause dangerous liver injury.
What Causes Codeine Withdrawal?
The immediate cause is a rapid reduction in opioid activity after the body has become physically dependent. Several situations can trigger it:
- Stopping prescribed codeine suddenly after regular use
- Reducing the dose faster than the body can comfortably adjust
- Missing multiple doses because a prescription runs out
- Losing access to codeine used without medical supervision
- Receiving naloxone during an overdose
- Starting naltrexone while opioids are still in the body
- Beginning buprenorphine too soon after the last full-opioid dose
Naloxone-related withdrawal can be abrupt and intense, but naloxone should never be withheld during a suspected overdose. Restoring breathing takes priority. Starting buprenorphine or naltrexone, however, requires appropriate timing and professional guidance to avoid precipitated withdrawal.
The FDA prescribing information for codeine sulfate warns against abrupt discontinuation in physically dependent patients. The DailyMed codeine monograph also details dependence, metabolism, respiratory risks, and safe-discontinuation considerations.
How Codeine Withdrawal Is Evaluated
A clinician will usually ask what product was used, how much was taken, how often it was taken, when the last dose occurred, and whether alcohol, benzodiazepines, stimulants, or other opioids are involved. Honest answers help prevent medication interactions; they are not material for a courtroom drama.
The examination may assess pulse, blood pressure, temperature, pupil size, sweating, digestive symptoms, tremor, and alertness. Clinicians sometimes use the Clinical Opiate Withdrawal Scale to measure severity and guide treatment. Blood tests are not always required, but they may be ordered to check hydration, electrolytes, liver function, pregnancy status, or another suspected medical problem.
Treatments for Codeine Withdrawal
1. A gradual, individualized taper
For someone taking prescribed codeine who does not have an urgent safety problem, a clinician-guided taper may reduce withdrawal symptoms. There is no universally correct schedule. A plan should reflect the current dose, treatment duration, pain condition, previous taper attempts, mental health, and the patient’s response to each reduction.
The CDC opioid-prescribing guideline and the HHS tapering guide emphasize gradual, collaborative dose reduction. Rapid, nonconsensual tapers may worsen pain, withdrawal, emotional distress, and the risk of seeking opioids from unsafe sources. The Mayo Clinic tapering guide likewise recommends working with the prescribing team rather than improvising a schedule.
2. Medications for opioid use disorder
If the assessment identifies opioid use disorder, withdrawal management alone is rarely enough. Evidence-based medications can reduce cravings, support stability, and lower the risk of overdose:
- Buprenorphine partially activates opioid receptors, relieving withdrawal and cravings without producing the same effect as a full opioid agonist when taken as directed.
- Methadone is a full opioid agonist that can suppress withdrawal and cravings when provided through appropriately regulated treatment.
- Naltrexone blocks opioid effects and may help prevent return to use after detoxification. It must not be started until an adequate opioid-free interval has passed.
The National Institute on Drug Abuse, SAMHSA, American Society of Addiction Medicine, and Johns Hopkins Medicine all describe medication as a central evidence-based treatment for opioid use disordernot as a moral shortcut or merely “replacing one drug with another.”
3. Medicines targeting individual symptoms
Lofexidine, an FDA-approved non-opioid medicine, can reduce certain autonomic withdrawal symptoms. Clinicians may also use clonidine off-label for sweating, agitation, rapid heartbeat, and similar symptoms. Either medicine can lower blood pressure and requires appropriate screening and monitoring.
Depending on the person’s health, a clinician may recommend medicines for nausea, diarrhea, stomach cramps, pain, or insomnia. Over-the-counter products are not automatically harmless. Taking excessive loperamide for diarrhea, combining sedatives, or using several acetaminophen-containing products can cause severe injury.
4. Supportive care
Fluids, electrolyte replacement, small bland meals, clean clothing, a cool room, gentle movement, and a realistic sleep routine can make withdrawal more manageable. Counseling, peer support, and follow-up care address triggers and cravings that hydration alone cannot solve.
Alcohol, benzodiazepines, leftover sleeping pills, and unregulated products such as kratom should not be used as do-it-yourself detox tools. They may introduce new dependence, dangerous interactions, or overdose risk. The Department of Veterans Affairs tapering resource provides additional clinical information about monitoring and symptom management.
When Is Codeine Withdrawal an Emergency?
Seek urgent medical care for severe or persistent vomiting and diarrhea, inability to keep fluids down, fainting, confusion, chest pain, a seizure, severe agitation, hallucinations, suicidal thoughts, or signs of significant dehydration. Pregnant patients should not attempt an abrupt opioid detoxification without obstetric and addiction-care guidance.
Extreme sleepiness, slow or stopped breathing, blue or gray lips, pinpoint pupils, and inability to wake are signs of possible opioid overdose, not ordinary withdrawal. Administer naloxone if available and call 911 in the United States. Because tolerance declines after stopping codeine, returning to a previously tolerated dose can cause a fatal overdose.
Experiences During Codeine Withdrawal: What the Process Can Feel Like
The following examples are realistic composites created from commonly reported clinical experiences. They are not quotations from identifiable patients, and individual results will differ.
Experience 1: Dependence after prescribed pain treatment
Imagine a person who has taken codeine several times a day for several months after an injury. The medication was used as directed, and there was no intoxication or compulsive drug-seeking. When the pain improved, the person decided to stop the tablets over a weekend.
The first evening seemed manageable. By the following morning, however, sleep had vanished, the legs felt restless, and a strange combination of sweating and chills had begun. A runny nose suggested a cold until the yawning, anxiety, and muscle aches arrived together. Later, stomach cramps and diarrhea made it obvious that something more systematic was happening.
The experience felt frightening partly because the person had interpreted dependence as proof of addiction. After contacting the prescriber, the patient learned that physical dependence can occur during legitimate treatment. The clinician checked for complications, restarted an appropriate dose, and designed a slower taper. Smaller reductions, regular follow-up, physical therapy, and non-opioid pain strategies made the next attempt far more tolerable.
The practical lesson was not that tapering is effortless. It was that discomfort can provide useful feedback. A taper producing overwhelming symptoms may need to pause or slow down. Recovery is not improved by turning the process into a contest of willpower.
Experience 2: Withdrawal connected with opioid use disorder
Another person may begin with prescribed codeine but eventually take larger amounts, obtain pills outside medical care, or use other opioids when codeine is unavailable. Each attempt to stop brings diarrhea, insomnia, panic, and cravings. After two or three days, taking an opioid again seems like the only way to function.
This cycle can create deep shame: stop, become sick, return to use, promise that next time will be different. Yet the pattern is consistent with a treatable health condition. When the person finally seeks care, the clinician evaluates withdrawal, overdose history, mental health, and other substance use. Buprenorphine is started at the appropriate time, reducing both withdrawal and cravings. Counseling helps identify triggers, while naloxone and overdose education improve safety.
The first week is not magically perfect. Sleep remains uneven, energy returns gradually, and ordinary responsibilities can feel surprisingly heavy. What changes is that every hour is no longer organized around avoiding withdrawal. Regular treatment creates enough stability to repair relationships, address pain, and rebuild routines.
Shared lessons from withdrawal experiences
People often report that nights feel longer than days, cravings rise and fall like waves, and progress becomes easier to see when measured by weeks rather than minutes. Support from one calm, informed person can make an enormous difference. Preparing fluids, arranging transportation, reducing unnecessary obligations, and scheduling follow-up before symptoms peak are practical forms of treatmentnot decorative extras.
Setbacks also need perspective. A return to opioid use is a warning that the treatment plan needs adjustment, not evidence that the person is hopeless. Because tolerance can fall quickly, any return to use carries increased overdose risk. Remaining connected to medical care, having naloxone nearby, and considering ongoing medication for opioid use disorder can be lifesaving.
Conclusion
Codeine withdrawal occurs when a physically dependent body must suddenly function with much less opioid activity. Symptoms commonly begin within a day, intensify over the next two or three days, and improve during the first week, although insomnia, fatigue, mood changes, and cravings may last longer.
A supervised taper may be appropriate for dependence related to prescribed treatment. When opioid use disorder is present, buprenorphine, methadone, or properly timed naltrexone can support longer-term recovery. The safest plan treats withdrawal, pain, mental health, overdose risk, and personal circumstances together. In other words, the goal is not merely to survive several miserable daysit is to build a safer life after them.
Editorial note: This educational article was synthesized from current guidance and clinical information published by the FDA, DailyMed, MedlinePlus, CDC, HHS, NIDA, SAMHSA, Mayo Clinic, Cleveland Clinic, ASAM, the Department of Veterans Affairs, and Johns Hopkins Medicine. It should not replace diagnosis or treatment from a qualified health professional.
